June Raine will step into the interim role of chief executive of the UK’s Medicines and Healthcare products Regulatory Agency (MHRA). She will replace outgoing chief executive, Ian Hudson, who has stepped down six years in the role and 18 years with the agency.
Raine has worked at the agency since its formation in 2003 and currently holds the position of director of the agency’s Vigilance and Risk Management of Medicines division. In addition, she held the role of chair of the European Pharmacovigilance Risk Assessment Committee for the European Medicines Agency from 2012 to 2018.
Outgoing chief executive, Dr Ian Hudson, said: “It has been a pleasure and privilege to have worked with so many able and committed people over the past 18 years. Our agency makes a real difference to the health of millions of people in the UK, Europe and beyond, and it has been an honor to make a contribution to this work.”